Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 6859-3 (miR-6859-3p) is a human microRNA implicated in post-transcriptional regulation of gene expression. Recent studies identified miR-6859-3p as an indirect modulator of SOX9 mRNA and protein levels in breast cancer cell lines; its repressive effects on SOX9 appear to be mediated via complex regulation of transcriptional activators and other microRNAs rather than direct binding to the SOX9 3′UTR. Unlike classic therapeutic targets, miR-6859-3p functions as part of a regulatory network, influencing cellular pathways such as chromatin organization and cell cycle control. Its role in cancer biology may be cell-type specific and indirect; no drugs currently target miR-6859-3p, and it is not used as a clinical biomarker or has identified safety liabilities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 6859-3 (miR-6859-3p).